We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Dirui Industrial

DIRUI Industrial Co., Ltd provides laboratory equipment and clinical diagnostic reagents for the in-vitro diagnostic ... read more Featured Products: More products

Download Mobile App





DIRUI Exhibits Latest Lab Automation Technologies and Devices

By LabMedica International staff writers
Posted on 06 Feb 2024

DIRUI Industrial Co. More...

(Jilin Province, China) is presenting its latest lab automation technologies and devices at Medlab Middle East 2024, including its advanced analyzers for clinical chemistry, urine analysis, and hematology testing.

At Medlab Middle East 2024, DIRUI is showcasing the MUS-3600 urinalysis system featuring four formed element modules that incorporate two urine analysis modules, and has a throughput of up to 480 T/H (for hybrid). It allows up to 580 urine samples to be loaded at one time and features a friendly design with a one-key QC & calibration function. DIRUI is also showcasing the BF-7200 automatic hematology analysis system which can test for 29 parameters, 2 scattergrams and 2 histograms, 7 parameters, 1 scattergram, and 1 histogram. It has a maximum throughput of 480T/H/CBD+DIFF 4 modules and comes with the prompt function of pathology and morphology abnormality alarm.

At the DIRUI booth at Medlab Middle East 2024, visitors can experience the CS-T240Plus fully automated chemistry analyzer which is a powerful desktop device with a constant throughput of 240 tests/ hour and optional ISE throughput of 480 tests/ hour. It performs whole blood testing for HbA1c and delivers accurate results using low minimum reaction volume and saving reagents. The CS-T240Plus has a water consumption of only 3L per hour and features a water quality check function for reliable results.

Related Links:
DIRUI Industrial Co.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
MEDLAB 2024
Copyright © 2000-2026 Globetech Media. All rights reserved.